DDX53 and neoplasm: Furthermore, survival (evaluated as the time for the tumor to reach 2000 mm3) analysis indicated that the median survival for the combination was 47 days, much longer than the 29.5 days for LPP-CT26 (P < 0.001) and 35 days for a-PD1 (P < 0.05) (Fig. 8F).